Dr. Andrew D. Goldberg has served as Achieve Life Sciences' Chief Executive Officer and President and as a director since April 2026, succeeding Richard Stewart. He previously served as a portfolio manager at Marshall Wace North America L.P. from February 2024 to April 2026 and as a managing director there from March 2021, and before that as a principal and later partner at Vivo Capital, a global healthcare investment firm, from 2016 to 2021; earlier he was a consultant at McKinsey & Company advising pharmaceutical, medical-device and biotechnology companies. Dr. Goldberg sits on the board of Tarsus Pharmaceuticals (since 2020) and Inquis Medical (since 2024) and has been a director or board observer at numerous life-sciences companies. He is a U.S. board-certified physician in both Critical Care Medicine and Emergency Medicine, has been an Instructor in Medicine at the Mayo Clinic College of Medicine, and received his M.D. from The George Washington University School of Medicine and a post-doctoral diploma in translational science from the Mayo Graduate School.